MDS)
Showing 26 - 50 of 3,289
MDS/MPN Trial in Nashville (ASTX727, Itacitinib)
Recruiting
- MDS/MPN
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Jun 20, 2022
Myeloproliferative Tumor, Chronic Neutrophilic Leukemia, MDS Trial in Tampa (Fedratinib Pill)
Recruiting
- Myeloproliferative Neoplasm
- +2 more
- Fedratinib Pill
-
Tampa, FloridaMoffitt Cancer Center
Jun 15, 2022
MDS Trial in Saint Louis (DEC-C, MyeloSeq-HD)
Recruiting
- Myelodysplastic Syndromes
- DEC-C
- MyeloSeq-HD
-
Saint Louis, MissouriWashington University School of Medicine
Jan 18, 2023
Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Minneapolis (N-803)
Completed
- Acute Myelogenous Leukemia (AML)
- Myelodysplastic Syndrome (MDS)
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Jan 4, 2023
Myelodysplastic Syndrome (MDS) Trial in Worldwide (sabatolimab, azacitidine, venetoclax)
Active, not recruiting
- Myelodysplastic Syndrome (MDS)
- sabatolimab
- +2 more
-
Brasschaat, Belgium
- +9 more
Jan 19, 2023
Acute Myeloid Leukemia, MDS Trial (Galinpepimut-S)
Available
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- Galinpepimut-S
- (no location specified)
Oct 20, 2022
Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Valhalla (Gemtuzumab Ozogamicin)
Active, not recruiting
- Acute Myelogenous Leukemia
- Myelodysplastic Syndrome
- Gemtuzumab Ozogamicin
-
Valhalla, New YorkNew York Medical College
Sep 26, 2022
MDS Trial in Tampa (Canakinumab Injection, Darbepoetin Alfa)
Recruiting
- Myelodysplastic Syndromes
- Canakinumab Injection
- Darbepoetin Alfa
-
Tampa, FloridaMoffitt Cancer Center
Nov 21, 2022
MDS, Myeloid Leukemia, Allogeneic Stem Cell Transplantation Trial in Pittsburgh (IFN-? (interferon gamma-1b) injection)
Recruiting
- Myelodysplastic Syndromes
- +2 more
- IFN-γ (interferon gamma-1b) injection
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Jan 5, 2023
MDS Trial (Fasting-mimicking diet (FMD) and physiotherapy)
Not yet recruiting
- Myelodysplastic Syndromes
- Fasting-mimicking diet (FMD) and physiotherapy
- (no location specified)
Jun 22, 2022
MDS, Acute Myeloid Leukemia With Myelodysplasia Related Disease and < 30% Blasts, Mixed Myelodysplastic/Myeloproliferative
Recruiting
- Myelodysplastic Syndromes
- +2 more
- Azacitidine
- +2 more
-
Stockholm, SwedenDepartment of Hematology, Karolinska University Hospital
Mar 27, 2023
Low Risk MDS Trial (R906289 Monosodium (R289 Na))
Not yet recruiting
- Low Risk Myelodysplastic Syndromes
- R906289 Monosodium (R289 Na)
- (no location specified)
Jul 22, 2022
MDS, Myeloproliferative Tumor Trial in United States (Azacitidine Subcutaneous Injection or Intravenous Infusion, Pevonedistat
Active, not recruiting
- Myelodysplastic Syndromes
- Myeloproliferative Neoplasm
- Azacitidine Subcutaneous Injection or Intravenous Infusion
- +2 more
-
Miami, Florida
- +4 more
Jun 20, 2022
Whole Genome Sequencing, MDS Trial in Saint Louis (ChromoSeq)
Recruiting
- Whole Genome Sequencing
- Myelodysplastic Syndromes
- ChromoSeq
-
Saint Louis, MissouriWashington University School of Medicine
Aug 1, 2022
Acute Myeloid Leukemia, MDS Trial (Cladribine, Cytarabine, Decitabine)
Not yet recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- Cladribine
- +4 more
- (no location specified)
Mar 1, 2023
Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Hematopoietic Stem Cell Transplant (HSCT) Trial in Pittsburgh
Active, not recruiting
- Acute Myeloid Leukemia (AML)
- +2 more
- Reduced-Intensity Conditioning Regimen
- Myeloablative Conditioning Regimen
-
Pittsburgh, PennsylvaniaUPMC Children's Hospital of Pittsburgh
Jan 4, 2023
Clonal Cytopenia of Undetermined Significance, MDS Trial in Saint Louis (Atorvastatin, Rosuvastatin)
Not yet recruiting
- Clonal Cytopenia of Undetermined Significance
- Myelodysplastic Syndromes
-
Saint Louis, MissouriWashington University School of Medicine
Jul 28, 2022
Acute Myeloid Leukemia, MDS, Myeloid Malignancies Trial in Boston (Decitabine, Filgrastim)
Not yet recruiting
- Acute Myeloid Leukemia
- +6 more
-
Boston, Massachusetts
- +1 more
Mar 31, 2023
Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial (LP-108, Azacitidine)
Not yet recruiting
- Acute Myeloid Leukemia
- +2 more
- (no location specified)
Nov 29, 2022
Acute Myeloid Leukemia (AML), High-risk Myelodysplastic Syndrome (MDS) Trial in Worldwide (HDM201, MBG453, Venetoclax)
Active, not recruiting
- Acute Myeloid Leukemia (AML)
- High-risk Myelodysplastic Syndrome (MDS)
- HDM201
- +2 more
-
Durham, North Carolina
- +8 more
Dec 13, 2022
AML, MDS Trial in Tuebingen (Decitabine, Venetoclax)
Recruiting
- AML
- MDS
-
Tuebingen, Baden-Wuerttemberg, GermanyUniversity Hospital
Nov 30, 2023
MDS Trial in Seoul (cyclophosphamide, fludarabine, and antithymocyte globulin)
Active, not recruiting
- Myelodysplastic Syndromes
- cyclophosphamide, fludarabine, and antithymocyte globulin
-
Seoul, Korea, Republic ofAsan Medical Center, University of Ulsan College of Medicine
Oct 19, 2023